A Message from Bradley Bale, MD and Amy Doneen, DNP, ARNP
Genetics will drive the future of healthcare and enhance precision medicine, which is now endorsed by the National Institutes of Health and the U.S. National Research Council. We are proud to introduce our genetic webcast series for clinicians explaining the clinical utility of newly available genetic tests to identify cardiovascular (CV) risk and how data from these tests can improve patient management. Simple therapies to potentially enhance the CV health of at-risk patients will also be discussed.
Advance your scientific knowledge by viewing our webcasts conveniently at home or in your office.
BaleDoneen Method Genetic Online Course: Clinical Application of Genetic Testing to Enhance Cardiovascular Care: Atrial Fibrillation-AF and 4Q25.
Speaker: Amy L. Doneen, DNP, ARNP.
This program demonstrates the clinical application of genetic testing through the lens of atrial fibrillation (AF) and the 4Q25 gene. This course brings the latest data on AF, which affects 33 million Americans, and genetic testing for the 4Q25 gene that raises AF risk by up to 70% into the arena of family practice, specifically focusing on early diagnostics, prevention and monitoring of this common and dangerous cardiac arrhythmia through individualized patient management.
- BaleDoneen Method Genetic Online Course: Clinical Application of Genetic Testing to Enhance Cardiovascular Care: Familial Hypercholesterolemia-FH.. Speaker: Bradley F. Bale, MD.
Patients with familial hypercholesterolemia (FH) have a five times higher risk of cardiovascular (CV) mortality if untreated. Studies report that only 20% of those with FH are currently diagnosed. This course covers genetic testing to identify patients with homozygous FH (HoFH), a rare genetic disease that creates significant risk for a fatal heart attack before age 20; and heterozygous FH, a relatively common disease that raises risk for CV events in young adults. New therapies are available to significantly reduce CV risk in HoFH and HeFH patients.
- BaleDoneen Method Genetic Online Course: Clinical Application of Genetic Testing to Enhance Cardiovascular Care: Haptoglobin-Hp. Speaker: Bradley F. Bale, MD.
Haptoglobin genotype is a screening for type 2 diabetic patients at risk for cardiovascular disease (CVD). This course elucidates the key functional differences in the Hp 1 genotype versus Hp 2, as well as the potential role of Hp 2’s precursor protein, zonulin, in autoimmune disease and cancer risk. Simple therapies to potentially enhance the health of Hp 2 patients will be discussed and how to personalize care through Hp genotyping.
- BaleDoneen Method Genetic Online Course: Women and CVD. Speaker: Amy L. Doneen, DNP, ARNP.
Currently 65% of women who die suddenly of a heart attack didn’t know they had have heart disease. Women at high risk of CVD are often missed using standard-of-care evaluation techniques. This course focuses on the uniqueness of women with special attention to their cardiovascular red flags, genetic testing and specific treatment recommendations critical to allow women optimal cardiovascular wellness.